Xingruida XDR
Finnrick has tested 65 samples from Xingruida XDR across 6 products.
Finnrick Vendor Profile
to
Xingruida XDR
Tracking 6 products
65 total samples tested
Last test 13 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Melanotan II | 2 | 18 Jul 2025 | 31 Jul 2025 | |||||
| BPC-157 | 7 | 24 Jul 2025 | 26 Feb 2026 | |||||
| GHK-Cu | 8 | 25 Nov 2025 | 9 Feb 2026 | |||||
| Tesamorelin | 6 | 17 Jul 2025 | 11 Feb 2026 | |||||
| Retatrutide | 23 | 20 Jun 2025 | 13 Mar 2026 | |||||
| Tirzepatide | 19 | 4 Sep 2025 | 2 Mar 2026 | |||||
The Xingruida XDR samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.1
Based on 8 overall satisfaction reports
Ease of Purchase4.1(8)
Payment Methods4.1(8)
Delivery Speed3.8(8)
Packaging Quality4.5(8)
Customer Service4.9(8)
People who submitted test requests to Finnrick gave Xingruida XDR an average satisfaction rating of 4.1 out of 5 across 8 reports associated with samples received and tested by Finnrick. Customers rated customer service (4.9/5) particularly highly.
Most recent Xingruida XDR tests
Samples are tested in commercial labs
65
tests
6
products
Scores
AVGMINMAX
First
20 Jun 2025
Last
13 Mar 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 13 Mar 2026 | Retatrutide | View | 15mg | 16.1mg | +7.3% | 99.80% | 07/02/25 | White Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 2 Mar 2026 | Tirzepatide | View | 30mg | 17.7mg | -41.0% | 99.90% | Blue Cap | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 26 Feb 2026 | Retatrutide | View | 10mg | 9.75mg | -2.5% | 99.90% | Dec 02,2025 | White Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 26 Feb 2026 | BPC-157 | View | 10mg | 8.65mg | -13.5% | 99.88% | Dec 02,2025 | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 18 Feb 2026 | Tirzepatide | View | 60mg | 53.4mg | -11.0% | 99.14% | (no batch ID) | No Label / Silver Crimp / Clear Green Cap | Lab E | Public | |
| 18 Feb 2026 | Tirzepatide | View | 60mg | 54.4mg | -9.3% | 99.38% | (no batch ID) | No Label / Silver Crimp / Clear Green Cap | Lab E | Public | |
| 15 Feb 2026 | Retatrutide | View | 10mg | 10mg | 99.70% | January 2, 2026 | No Label / Silver Crimp / Yellow Cap | Lab G | Public | ||